A
ACHIEVE LIFE SCIENCES INC
NASDAQ: ACHV (Achieve Life Sciences, Inc.)
最近更新时间: 4小时之前6.83
-0.36 (-5.01%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Achieve Life Sciences, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 相对估值 | NA |
| 财务健康 | -1.2 |
| 宏观环境 | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -0.97 |
|
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 9.69% |
| 机构持股比例 | 41.59% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Tpg Gp A, Llc | 30 Jun 2026 | 6,877,580 |
| Venbio Partners Llc | 30 Jun 2026 | 5,914,720 |
| Propel Bio Management, Llc | 30 Jun 2026 | 4,034,018 |
该时间范围内无数据。
投资组合